Directors Dealings
Director dealings are proprietary transactions by executives, which are reportable under Art. 19 MAR. The publication of these transactions is an important contribution to the prevention of insider dealing and market manipulation. In addition, knowledge of such transactions is of great importance to the market, as these transactions provide indications of management's assessment of the company's future business prospects. The information presented here relates to companies that are under the supervision of BaFin.
Symrise AG: A reportable insider transaction was published on 31st July 2025. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 31st July 2025,
The Insider Transaction was made by Klinger, Olaf 
. The transaction toke place on 31st July 2025. The order was executed at the trading place Lang % Schwarz Wertpapierhandelsbank AG. . The aggregated volume was 96.480,00 EUR, based on an average price of 80,40 EUR. The nature of the Investment was Buy.
TAG Immobilien AG: A reportable insider transaction was published on 13th June 2025. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 13th June 2025,
The Insider Transaction was made by Borkers, Olaf . The transaction toke place on 13th June 2025. . The aggregated volume was 3.353,34 EUR, based on an average price of 14,39 EUR. The nature of the Investment was not specified.
SAP SE: A reportable insider transaction was published on 13th June 2025. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 13th June 2025,
The Insider Transaction was made by Schick, Dr. Eberhard . The transaction toke place on 11th June 2025. The order was executed at the trading place CBOE EUROPE - DXE Order Books (NL). . The aggregated volume was 2.732,88 EUR, based on an average price of 264,94 EUR. The nature of the Investment was not specified.
Continental Aktiengesellschaft: A reportable insider transaction was published on 3rd June 2025. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 3rd June 2025,
The Insider Transaction was made by Schick, Olaf . The transaction toke place on 2nd June 2025. The order was executed at the trading place XETRA. . The aggregated volume was 357.259,49 EUR, based on an average price of 75,87 EUR. The nature of the Investment was Buy.
NanoRepro AG: A reportable insider transaction was published on 26th May 2025. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 26th May 2025,
The Insider Transaction was made by Stiller, Dr. Olaf . The transaction toke place on 26th May 2025. The order was executed at the trading place Tradegate. . The aggregated volume was 25.900,00 EUR, based on an average price of 1,29 EUR. The nature of the Investment was Buy.
SAP SE: A reportable insider transaction was published on 20th May 2025. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 20th May 2025,
The Insider Transaction was made by Schick, Dr. Eberhard . The transaction toke place on 16th May 2025. The order was executed at the trading place CBOE EUROPE - DXE ORDER BOOKS (NL). . The aggregated volume was 2.141,37 EUR, based on an average price of 266,82 EUR. The nature of the Investment was not specified.
NanoRepro AG: A reportable insider transaction was published on 19th May 2025. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 19th May 2025,
The Insider Transaction was made by Stiller, Dr. Olaf . The transaction toke place on 16th May 2025. The order was executed at the trading place XETRA. . The aggregated volume was 25.700,00 EUR, based on an average price of 1,28 EUR. The nature of the Investment was Buy.
NanoRepro AG: A reportable insider transaction was published on 8th May 2025. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 8th May 2025,
The Insider Transaction was made by Stiller, Dr. Olaf . The transaction toke place on 7th May 2025. The order was executed at the trading place Tradegate. . The aggregated volume was 5.001,07 EUR, based on an average price of 1,40 EUR. The nature of the Investment was Buy.
NanoRepro AG: A reportable insider transaction was published on 8th May 2025. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 8th May 2025,
The Insider Transaction was made by Stiller, Dr. Olaf . The transaction toke place on 6th May 2025. The order was executed at the trading place Tradegate. . The aggregated volume was 2.368,80 EUR, based on an average price of 1,41 EUR. The nature of the Investment was Buy.
Schaeffler AG: A reportable insider transaction was published on 3rd April 2025. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 3rd April 2025,
The Insider Transaction was made by Schick, Andreas . The transaction toke place on 2nd April 2025. The order was executed at the trading place XETRA. . The aggregated volume was 49.638,60 EUR, based on an average price of 3,76 EUR. The nature of the Investment was Buy.
NanoRepro AG: A reportable insider transaction was published on 27th March 2025. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 27th March 2025,
The Insider Transaction was made by Stiller, Dr. Olaf . The transaction toke place on 25th March 2025. The order was executed at the trading place TRADEGATE. . The aggregated volume was 7,10 EUR, based on an average price of 1,42 EUR. The nature of the Investment was Buy.
NanoRepro AG: A reportable insider transaction was published on 26th March 2025. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 26th March 2025,
The Insider Transaction was made by Stiller, Dr. Olaf . The transaction toke place on 24th March 2025. The order was executed at the trading place TRADEGATE. . The aggregated volume was 13.593,66 EUR, based on an average price of 1,42 EUR. The nature of the Investment was Buy.
NanoRepro AG: A reportable insider transaction was published on 26th March 2025. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 26th March 2025,
The Insider Transaction was made by Stiller, Dr. Olaf . The transaction toke place on 24th March 2025. The order was executed at the trading place XETRA. . The aggregated volume was 15.771,00 EUR, based on an average price of 1,40 EUR. The nature of the Investment was Buy.
NanoRepro AG: A reportable insider transaction was published on 25th February 2025. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 25th February 2025,
The Insider Transaction was made by Stiller, Dr. Olaf . The transaction toke place on 21st February 2025. The order was executed at the trading place XETRA. . The aggregated volume was 14.506,24 EUR, based on an average price of 1,28 EUR. The nature of the Investment was Buy.
NanoRepro AG: A reportable insider transaction was published on 17th February 2025. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 17th February 2025,
The Insider Transaction was made by Stiller, Dr. Olaf . The transaction toke place on 13th February 2025. The order was executed at the trading place XETRA. . The aggregated volume was 18.750,00 EUR, based on an average price of 1,25 EUR. The nature of the Investment was Buy.
Symrise AG: A reportable insider transaction was published on 31st January 2025. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 31st January 2025,
The Insider Transaction was made by Klinger, Olaf . The transaction toke place on 31st January 2025. The order was executed at the trading place XETRA. . The aggregated volume was 49.850,20 EUR, based on an average price of 99,70 EUR. The nature of the Investment was Buy.
APONTIS PHARMA AG: A reportable insider transaction was published on 10th December 2024. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 10th December 2024,
The Insider Transaction was made by Elbracht, Olaf . The transaction toke place on 4th December 2024. . The aggregated volume was 40.000,00 EUR, based on an average price of 10,00 EUR. The nature of the Investment was not specified.
CEWE Stiftung & Co. KGaA: A reportable insider transaction was published on 16th December 2024. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 16th December 2024,
The Insider Transaction was made by Holzkämper, Dr. Olaf . The transaction toke place on 13th December 2024. . The aggregated volume was 4.173,80 EUR, based on an average price of 101,80 EUR. The nature of the Investment was Buy.
SAP SE: A reportable insider transaction was published on 13th December 2024. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 13th December 2024,
The Insider Transaction was made by Schick, Dr. Eberhard . The transaction toke place on 11th December 2024. The order was executed at the trading place CBOE EUROPE - DXE Order Books (NL). . The aggregated volume was 4.341,29 EUR, based on an average price of 236,43 EUR. The nature of the Investment was not specified.
NanoRepro AG: A reportable insider transaction was published on 29th October 2024. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 29th October 2024,
The Insider Transaction was made by Stiller, Dr. Olaf . The transaction toke place on 28th October 2024. The order was executed at the trading place XETRA. . The aggregated volume was 17.300,00 EUR, based on an average price of 1,73 EUR. The nature of the Investment was Buy.
Disclaimer:
The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster.
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.
If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.